Prescribing and Dispensing ADF Opioids: A Survey of Physicians and Pharmacists

Results_ADF surveys

This poster (PDF: ADF Surveys Poster) was recently presented at the Academy Health Annual Research Meeting. Check out the link for detailed survey results and principal findings.

Authors: John R. Brown, Svetla Slavova, Nabarun Dasgupta, Patricia R. Freeman

Abuse-deterrent formulation (ADF) opioids represent an opportunity to deter the misuse and abuse of opioids. In the clinical setting, decisions by physicians and other practitioners directly impact who receives a prescription for an ADF opioid versus a traditional formulation. The identification of factors associated with ADF opioid prescribing is critical to inform clinical guidelines and policymaking.

Some key findings:

  • Percentages of physicians who reported having prescribed the products ranged from 11.4% (Hysingla® ER) to 49.6% (OxyContin®).
  • Less than half of pharmacists (43.2%) and physicians (30.6%) reported a belief that ADFs are an effective or very effective strategy in mitigating the misuse/abuse of prescription opioids.
  • Most pharmacists (66.6%) and physicians (73.7%) indicated they would support legislation which mandates third-party coverage of ADFs

To find out more information about this project, view the study page located here.

Pharmacist & Prescriber Surveys
Click to read the study
John Brown

Svetla Slavova

Nabarun Dasgupta
Epidemiologist, Factotum